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ABSTRACT 
Cephalosporins are the highly used Broad spectrum antibiotics, belong to β-lactam class . It was discovered by Brotzu in fungus 
Cephalosporium Acremonium which produces a chemical which show antimicrobial activity. Abraham isolated the three types of 
cephalosporin antibiotics cephalosporin P, cephalosporin N, cephalosporin C.7-ACA is widely used as the substrate for synthesizing 
cephalosporin antibiotics. Modification of the 7-ACA side-chains resulted in the development of useful antibiotic agents, and the 
first agent is Cephalothin (cefalotin) was launched by. Eli Lilly Company in 1964. Cephalosporins resemble penicillin  in that they 
have a β-lactam structure, but the five-member thiazolidine ring characteristic of the penicillin is replaced by a six-member 
dihydrothiazine ring. The bactericidal action of beta lactam antibiotics is directly attributable to their ability to react with PBP's. The 
research work relates to an improved and cost effective process for the industrial manufacture of Cefpodoxime Proxetil. More 
specifically it relates to preparation of products of good quality with high yield and the products are removed and the same can be 
recycled using simple industrial and viable method. It can be possible with by using intermediate MAEM to synthesize Cefpodoxime 
proxetil. The drug is registered in USP and belongs to 3rd generation drug. There are many patents which gives the procedure of 
Synthesis of Cefpodoxime Proxetil. These synthesis procedures have taken as standard procedure for pursuing the project work. At 
present, MAEM is highly used intermediate to synthesis cephalosporin antibiotics. In this project work modification has done for 
synthesizing  of cephalosporin antibiotics by utilizing MAEM as intermediate and other chemicals like different Lewis acid, and 
solvent  as alternate  of intermediate, chemicals and solvents which are given in patents to synthesize cephalosporin antibiotics 
.Resulting yield has improved via making small time synthesis reaction .This is helpful for the commercial purpose. The Reaction 
monitoring  were done by HPLC and identification of final product were done by MASS, I.R, NMR and then comparing with the 
well known literature. Recovery of the side product and byproduct (mercaptobenzothiazole) were achieved to allow a greener 
process and utilizes for synthesis of other familiar drugs. 
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1. INTRODUCTION: 
Since some years  ago  the  synthesis of  antibiotics  is  a 
branch of pharmaceutical  chemistry  to which some  
investments have been made  in order  to develop new 
compounds with antimicrobial activity.  In  1945, Brotzu  
discovered  the  fungus  Cephalosporium  Acremonium 
which  produce  a chemical which show antimicrobial 
activity. In 1948 Abraham at the Sir William Dunn 
School of Pathology at the University of Oxford and his 
colleagues have been supplied cultures of the fungus and 
were isolated three principal antibiotic components :i) 
Cephalosporin P, (a steroid antibiotic that resembles 
fusidic acid) with minimal antibacterial activity. ii) 
Cephalosporin N, later discovered to be identical with 
synnematin N (a penicillin derivative now called 
penicillin N.iii) Cephalosporin C it was isolated in 1952 
from a mold of the genus Cephalosporium
1.
 
A decade later the nucleus (7-aminocephalosporanic 
acid) was isolated and used as the basis for a series of 
synthetic derivatives, including Cephalothin, 
cephaloridine and Cephaloglycin. (a cephem containing 
ring now called nucleus of cephalosporin drugs). He 
noticed that these cultures produced substances that were 
effective against Salmonella Typhi, the cause of typhoid 
fever, which had beta-lactamase. The cephalosporin 
nucleus, 7-aminocephalosporanic acid (7-ACA), was 
derived from cephalosporin C and proved to be 
analogous to the penicillin nucleus 6-aminopenicillanic 
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acid, but it was not sufficiently potent for clinical use
.
 
Modification of the 7-ACA side-chains resulted in the 
development of useful antibiotic agents, and the first 
agent is Cephalothin (cefalotin) was launched by. Eli 
Lilly Company in 1964. 
The Cephalosporins are a class of β-lactam antibiotics 
originally derived from Acremonium, which was 
previously known as "Cephalosporium". Together with 
cephamycins they constitute a subgroup of β-lactam 
antibiotics called cephem. 
2,3
 Cephalosporins are among 
the most important antibiotics. Cephalosporins resemble 
penicillin
 
 in that they have a β-lactam structure, but the 
five-member
 
thiazolidine ring characteristic of the 
penicillin is replaced
 
by a six-member dihydrothiazine 
ring .The dihydrothiazine
 
ring of the cephalosporin 
provides the molecule with the ability
 
to resist bacterial 
enzymes; the antibacterial activity emanates
 
from the -
lactam ring shared by penicillin and Cephalosporins.
 4
 
Modifications at position 7 of the cephalosporin nucleus 
generally
 
affect the antibacterial spectrum, and 
substitutions at position
 
3 of the dihydrothiazine ring 
alter the pharmacokinetics and
 
metabolic parameters of 
the drug.  In  an  effort  to  obtain  derivatives  
possessing  a broader  antibacterial  spectrum,  greater  
stability  towards lactamases and  improved  
pharmacological  properties, modifications  of  the  
cephem  basic  skeleton is required. In cephalosporin 
nucleus there are two positions available for chemical 
manipulation, C3 and C7. A wide variety of amine 
acylation methods have  been  used  for  the  production  
of  C7- acylamino derivatives by the use of acyl 
chlorides,  mixed  anhydrides,  active  esters,  and 
carbodiimides to improve pharmacodynamic property . 
To improve the chemical reactivity of 7-ACA, the 
solubility in organic solvents  is  increased  by  
conversion of the  carboxylic  acid at C4 of 7-ACA  into  
an ester such as tert-butyl dimethylsilyl,  benzhydry1,p-
nitrobenzyl,  o-p-methoxybenzyl to improve 
pharmacokinetic property .   
The cephalosporin nucleus can be modified to gain 
different properties. Cephalosporins are sometimes 
grouped into "generations" by their antimicrobial 
properties. The first Cephalosporins were designated 
first-generation Cephalosporins, whereas, later, more 
extended-spectrum Cephalosporins were classified as 
second-generation Cephalosporins. Each newer 
generation of Cephalosporins has significantly greater 
Gram-negative antimicrobial properties than the 
preceding generation, in most cases with decreased 
activity against Gram-positive organisms. Fourth-
generation Cephalosporins, however, have true broad-
spectrum activity.5 
2. MATERIALS & METHODS: 
2.1 Experimental Part 
Synthetic Preparation of Cefpodoxime Proxetil 
 
1. Prepration of 7-amino 3-methoxy,3-cephem-4-carboxylic acid from 7-amino cephalosporanic acid. 
 
N
SH2N
O
COOH
O CH3
O
N
SH2N
O
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O
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2.methanol
47-500C
7-ACA
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 Charged sulfolane 32g in dry four neck round 
bottom flask and checked moisture. 
 Cooled down to 100c and purged 95g boron 
triflouride gas at 10 to 25
0
c.  
 After purging BF3 added methanol 70 gm at 25 to 
45
0
c. 
 Charged 25 gm 7-ACA at 45 to 460c. 
 Raised the temp. to 47 to 500c & stirred the reaction 
mass till Rx completion.(Rx is monitered by HPLC 
Method). Its Rx monitoring is shown below. 
 After Rx completion poured the Rx mass in to 
prechilled mixture of 500ml DM water+250 ml 
MDC+25g NaCl. 
 Stirred,settled and separated the aqueous layer. 
 Took aqueous layer and charged 900ml MDC.Again 
sepaerate the aqueous layer & charged again MDC 
In aqueous layer. 
 Stirred,settled and separated out it. 
 Collect total organic layer,adjust pH 7.0 to 7.2 with 
20% NaOH sol’n 
    Stirred the mass 15 min. again left for seperation. 
 Collect both aqueous layer & charged 0.5g EDTA at 
15-20
0
c. 
 Adjust  the pH 1.0 to 1.2 with TEA at 15 to 200c. 
 Stirred the Rx mass 30-40 min. at 15-200c. 
 Again TEA added in mixture to adjust the final pH 
2.92 to 3.10. 
 Again stiirred for few min.at room temp. 
 Filtered it & washed  with 100ml water & 100 ml 
methanol. 
 Dry it by vaccum pump & proceed in next stage.
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2. Preparation  of  Cefpodoxime Acid(crude) from 7-AMCA. 
N
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 Charged Methanol 110 ml and wet 7 – AMCA at RT 
 Cool down to 100c , charged MAEM 23 gm at 100c 
and flush with 10 m MeOH.  
 Added TEA 7.5 gm slowly  In 30 to 45 min. at 10 – 
12
0
c 
 Stirred reaction mix at 10-120c till reaction 
completion. 
 After  reaction completion charged 560 ml DM water 
and adjusted pH 5.4 to 5.5 with  5% sulphuric acid. 
 Cooled down to 50c and stirred 20 min. 
 Filtered and washed MBT with 50 ml DM water. 
 Took clear filtrate and charged 2.5 gm carbon , 0.5 
gm hydro and 0.25 gm EDTA. 
 Stirred 30 min. at 20 -250c. 
 Filtered and washed carbon bed with 50 ml DM 
water. 
 Took clear filterate and added 5% sulphuric acid up 
to haziness at 25 – 300c. 
 Stirred 30 min. at 25 – 300c. 
 Finally adjusted  pH 2.5 with 5% sulphuric acid. 
 Cooled down to 0 – 50c. and stirred 60 min at 0 -50c.  
 Filtered and washed with –(a) 50 ml DM water 
o (b) 2*90 ml Acetone. 
 Sucked properly and unloaded the wet material. 
 Dried in the TD at 45 to 500c till moisture content 
less than 1.2% w/w. 
 
    3. Preparation of Side Chain Of  Cefpodoxime Proxitil 
H3C O O CH3
Cl
CH3
O
H3C O O CH3
I
CH3
O
NaI,KBr
1100C
Azeotropic 
reflux
CHLORO COMPD. IODO COMPD.
 
 
 Charged toluene 280 ml at 250c. 
 Charged sodium idide 25.344 gm , potassium 
bromide 0.225 gm and crown ether 2.8 gm at 25C. 
 Raised the temp. up to 1100c for azeotropic reflux. 
Stirred till m.c.≤0.05% at 1100c. 
 Charged chloro 25 gm compound at 100 -1030c. 
 Stirred reaction mix at 103 -1050c till reaction 
completion ( chloro ≤ 10.0%) 
 After reaction completion , cooled down to the 
reaction mix to 25 – 300c. 
 Charged sodium thio sulphate  solution (8.44 gm in 
56.32 ml DM water). 
 Stirred 15 min. settled and seperated organic layer. 
 Took organic layer and washed with sodium chloride 
solution ( 7.80 gm NaCL in 56.32 ml DM water). 
 Took organic layer and dried over 16.89 gm sodium 
sulphate. 
 Took organic layer and distilled out toluene under 
vaccum at 35 – 400c. 
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  4.     Prepration Of Cefpodoxime Proxetil From Cefpodoxime Acid.  
4. ADDITION OF SIDE CHAIN :
S
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 Charged DMAC 150ml at 20-250c. 
 Charged CPDA 30g at 20-250c. 
 Stirred till clarity at RT. 
 Cooled it to -5 to -100c. 
 Add DBU 10.67 gm at -5 to -100c.stirred 10 to 20 
min. 
 Cooled it to -15 to -200c.Added side chain 21gm at-
15 to -20
0
c. 
 Stirred Rx mass at -15 to -200c till Rx completion. 
 After Rx completion poured reaction mix.into(6.3g 
sodium thiosulphate+840ml DM water+285 ml ethyl 
acetate)sol’n. 
 Stirred 15 min. settle and separate the layer. 
 Took aqueous layer and extracted with 190ml ethyl 
acetate. 
 Combined both ethyl acetate layer and washed 
with(192ml DM water+1.52g hydro+9g NaCl+1.86g 
sodium thio sulphate) solution two times. 
 Took ethyl acetate layer , charged 4.5  gm carbon and 
0.352 gm EDTA at 20 – 250c. 
 Stirred 30 min. at 20 – 250c. filtered and washed 
carbon bed with 61 ml ethyl acetate. 
 Took clear filtrate and distilled out ethyl acetate 
under vaccum at 30 -35
0
c till 45.17 ml remains in 
RBF. 
 Charged 45.17ml methanol and distilled  out ethyl 
acetate and methanol mix. Under vaccum till 45ml 
remain in RBF. 
 Repeated above step. 
 Charged 113.99 ml methanol and 17 ml(1:1HCL) 
Sol’n. 
 Stirred 10 min. at 20 -250c. 
 Dispersed reaction mix into 750 ml DM water and 
maintained the pH 4 – 4.1 by 5% ammonia solution 
at 25 – 280c. 
 Stirred 30 min. at 25 -280c 
 Cooled down to 10 – 150c. 
 Stirred 60 min. 10 -150c. 
 Filtered and washed with 150 ml DM water three 
times. 
 Unloded and dried in hot air oven till M.C.≤2.0%. 
 
 
3. RESULTS AND DISCUSSION: 
3.1. Physical Parameters6, 7  
The Physical appearances and odors of following compound are:  
Table: 1 
   Compound        Appearances  Color   Odors 
Cefpodoxime Proxetil   Crystalline Powder White to lightish brown Having a faint odor 
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3.2 Solubility Parameters 8,9 
The solubility of synthesized compound is as follows: 
Table: 2 
Compound Solubility 
Cefpodoxime Proxetil Very slightly soluble in water, Soluble in acetonitrile and in methanol. Freely soluble in 
dehydrated alcohol Slightly soluble in ether. 
 
3.3 Determination of Melting Point Range:  
Melting points of the newly synthesized compounds were determined by open capillary method using the melting point 
apparatus. The melting points of synthesized compounds are given in  
Table 3: 
             Compound                Melting point (
0
c) 
  Cefpodoxime Proxetil                   111-114 
 
3.4 HPLC Parameters of Compounds
 10, 11
 
The retention times of following compounds are as follows: 
Table: 4 
s.no Compounds              Retention Time 
1 7-ACA               6.26-6.30  
2 AMCA               3.80-3.90 
3 ADCA               3.23-3.27 
4 Chloro Compd.               8.51-8.55 
5 Iodo Compd.               10.50-10.55 
6 MAEM                16.70-16.75 
7 CPDA               7.92-7.83 
8 
 
CPPN-A 
CPPN-B 
              10.78-10.80 
               9.73-9.80 
9 Cefpodoxime proxetil               12.31-12.35 
 
Spectra Analysis 
 3.5 I.R of the synthesized compound: 
The functional groups of synthesized compounds can be concluded from the value of I.R spectra, it is also an 
identification source of the compound: 
Table: 5 
                       COMPOUND  Common Value Interpretation 
S
N
H2N
NOCH3
O
NH
N
S
O
COO-Na+
O CH3
O  
-1745 stretch 
-1600Asym. 
1400 symm. 
-1690-1640                  
3350&3180 
1740-1715 
-β-lactam amide 
-showsalt 
formation 
-Oxime peak 
-Primary amine 
-Ester peak 
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3.6 Interpretation of Mass Spectra of Following Synthesizes Compound: 
Table: 6 
       Compound    Molecular Weight       Base Peak Molecular ion peak 
Cefpodoxime Proxetil      557.60         558.1          558.1 
 
3.7 Interpretation of NMR Spectra of following Synthesizes Compound:
12
 
 Cefpodoxime proxetil:  
H-NMR  (DMSO-d6):  9.62  (m,  1H,  NHCO),  7.25  (s,  2H,  NH2),  6.87  and  6.81  (2q,  1H, OCH(CH3)O),  6.74  
(s,  1H,  thiazole),  5.85  (m,  1H,  H-7),  5.20  (m,  1H,  H-6),   
4.82 (m, 1H, OCH (CH3)), 4.15 (s, 2H, CH3OCH2), 3.83 (s, 3H, NOCH3), 3.65 and  
3.52 AB, q, 2H, H-2), 3.20(s, 3H, CH2OCH3), 1.49 (d, 3H, CH3CH), 1.25 (m, 6H, (CH3)2). 
 
These all described data confirms the synthesized drugs. 
  5.8 Yield of Following Synthesized Products 
The theoretical yield & practical yield are calculated on the basis of substrate i.e In case of CPPN and Cefotaxime, 7-
ACA is taken as substrate and &7-ADCA is taken as substrate for Cefetamet. All value of yield are calculates in 
reference of 50 g substrate. 
Table: 7 
Compound Theoretical yield Practical yield      %yield 
Cefpodoxime Proxetil 102.45gm 86.96gm 84.89 
 
CONCLUSION: 
The use of MAEM as starting material  for preparing cefpodoxime Proxetil,   allowed  to obtain better  yields  for  the  
synthesis  of  these  antibiotics.  Previous  esterification  of  the  chloroacetylated derivative followed by  cleavage of  
the  chloroacetyl protective group, allowed  to eliminate  the drawbacks  of  the  classic pathways of  synthesis,  
especially  the  final  purification  of  cefpodoxime Proxetil by column  chromatography. Moreover, the utilization of 
MAEM allows diminish the production cost of the final product. The  reaction  time  has  been  reduced  by  lowering  
the  time  for  acylation.  The overall yield has been increased to 91% with good.  Recovery of the byproduct 
(mercaptobenzothiazole)
 
was achieved to allow a greener process. 
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Table 1.1: List of Chemicals Used In Isolation Process 
Chemical Name           Grade           Company 
ACETONE B            (For Synthesis)             SPECTROCHEM 
TEA A            ( For Synthesis)        Qualigens Fine Chemicals, Mumbai  
BSA A             ( For Synthesis)             ALDRICH 
ETHYL ACETATE A             ( For Synthesis)             SPECTROCHEM 
SULFOLANE A             ( For Synthesis)             S.D Fine Chemicals, Mumbai 
METHANOL B             ( For Synthesis)             SPECTROCHEM 
7ACA            SANDOZ 
SULPHURIC ACID B                ( For Synthesis)           SPECTROCHEM 
MDC B              ( For Synthesis)           SPECTROCHEM 
THF B              ( For Synthesis)            SPECTROCHEM 
EDTA B              ( For Synthesis)            SPECTROCHEM 
MAEM                 SANDOZ 
CARBON A            SPECTROCHEM 
SODIUM IODIDE A             ( For Synthesis)               MERCK 
POTASSIUM BROMIDE B              ( For Synthesis)               MERCK 
SODIUM THIOSULPHATE B              ( For Synthesis)              ALDRICH 
TOLUENE A              ( For Synthesis)              SPECTROCHEM    
CROWN ETHER A             ( For Synthesis)                ALDRICH 
CHLORO COMPD. B             ( For Synthesis)              SPECTROCHEM 
SODIUM SULPHATE B              ( For Synthesis)              SPECTROCHEM 
AMMONIA B              ( For Synthesis)             SPECTROCHEM 
SODIUM  HYDROXIDE B              ( For Synthesis)           Qualigens Fine               
Chemicals, Mumbai 
DMAC B              ( For Synthesis)             SPECTROCHEM 
Hydrochloric Acid  Central Drug House (p)ltd. New Delhi 
Ortho-phosphoric acid  A             (HPLC grade)                  ALDRICH 
7-ADCA A             (HPLC grade)                   SANDOZ 
Sodium ethyl Hexonate B             ( For Synthesis) Central Drug House (p)ltd.  New Delhi 
Dimethyl formamide A              ( For Synthesis)              SPECTROCHEM    
 
Table 1.2: List of Chemicals Used In TLC and HPLC analysis 
Si. No. Name of Chemicals Grade of chemicals 
1 Chloroform HPLC grade, Merck 
2 Toluene AR grade, Merck 
3 Methanol HPLC grade, Merck 
4 Acetonitrile HPLC grade, Merck 
5 Formic acid AR grade, Merck 
6 Glacial acetic acid AR grade, Merck 
7 Acetone HPLC grade, Merck 
8 Ethyl acetate AR grade, Merck 
9 Water for HPLC HPLC grade, Merck 
 
 
4.4 NMR SPECTRA OF CEFPODOXIME PROXETIL 
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Spectrum 
S
N
H2N
HN
N
O
N
S
O O
O O O
O
O
O
6.6
4.0
8.0
5.45
5.1
3.11
6.61
1.74
4.31
1.35
1.35
4.04
3.24
4.01
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Protocol of the H-1 NMR Prediction:
Node   Shift    Base + Inc.   Comment (ppm rel. to TMS)
  CH    6.6         7.41      thiazole
                   -0.85      1 -N from 2-thiophene
                     ?        1 unknown substituent(s) from 3-thiophene
                     ?        1 unknown substituent(s) from 3-furan
                              -> 1 increment(s) not found
 NH2    4.0         4.00      aromatic C-NH
  NH    8.0         8.00      sec. amide
  CH    5.45        3.08      propiolactam
                    2.10      1 alpha -N-C=O from methine
                    0.27      1 beta -SR from methine
                     ?        1 unknown substituent(s)
  CH    5.1         3.42      propiolactam
                    1.04      1 alpha -SR from methine
                    0.62      1 beta -N-C=O from methine
                     ?        1 unknown substituent(s)
                     ?        1 -R from N-CHx
                              -> 1 increment(s) not found
 CH2    3.11        1.37      methylene
                    0.63      1 alpha -C=C
                    1.11      1 alpha -S-C
  CH    6.61        1.50      methine
                    0.17      1 alpha -C
                    4.94      2 alpha -O-C=O
 CH3    1.74        0.86      methyl
                    0.44      1 beta -OC(=O)-C=C
                    0.44      1 beta -OC(=O)
  CH    4.31        1.50      methine
                    0.34      2 alpha -C
                    2.47      1 alpha -O-C=O
 CH3    1.35        0.86      methyl
                    0.44      1 beta -OC(=O)
                    0.05      1 beta -C
 CH3    1.35        0.86      methyl
                    0.44      1 beta -OC(=O)
                    0.05      1 beta -C
 CH2    4.04        1.37      methylene
                    0.63      1 alpha -C=C
                    2.04      1 alpha -O-C
 CH3    3.24        0.86      methyl
                    2.38      1 alpha -O-C
 CH3    4.01        0.86      methyl
                    3.15      1 alpha -O-N=C  
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